Number of Trials
The following table compares the number of open trials
categorized by sponsor types in the 12-month reporting period
at NCI-designated Cancer Centers.
Figure 9. Number of Trials By Sponsor
| Number of Open Trials* |
| Sponsor |
Total |
Median |
| National Cooperative Group |
7,206 |
129 |
| Ext. Peer Reviewed |
2,251 |
29 |
| Institutional |
4,775 |
54 |
| Industry/Pharma |
3,948 |
62 |
| Not Specified |
625 |
0 |
| TOTAL TRIALS* --- 18,805 |
*It is important to note that these are not
necessarily unique trials; the same trial may be open at multiple centers.
| |
|
|
Number of Patients
The following table compares the number of patients accrued
to open trials categorized by sponsor types in the 12-month reporting period
at NCI-designated Cancer Centers.
Figure 10. Patient Accrual By Sponsor
| Number of Patients Accrued |
| Sponsor |
Total |
Median |
| National Cooperative Group |
18,397 |
221 |
| Ext. Peer Reviewed |
82,793 |
389 |
| Institutional |
93,344 |
534 |
| Industry |
14,946 |
175 |
| Other/Unknown |
21,588 |
0 |
| TOTAL PATIENTS --- 231,068 |
Descriptions of the sponsor categories used above can be found on page 12 in the
summary instructions.
|
